Ustekinumab in pediatric patients with Crohn's disease: safety, and efficacy results from a multicenter retrospective study in China

• Main Authors: Ping Li (Author), Lin Wang (Author), Zifei Tang (Author), Yuhuan Wang (Author), Zhanju Liu (Author), Wensong Ge (Author), Ying Huang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

BackgroundUstekinumab (UST) is approved as an effective therapy for Crohn's disease (CD) in adults. Off-label use is increasing in the pediatric population, more data on safety and efficacy in pediatric patients with CD is urgently needed.AimsThis study aimed to evaluate the clinical efficacy a...